Literature DB >> 27062661

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27062661     DOI： 10.1016/j.jhep.2015.11.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  856 in total

Review 1.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

2.  Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet.

Authors:  Yoshihiko Tashiro; Qinghong Han; Yuying Tan; Norihiko Sugisawa; Jun Yamamoto; Hiroto Nishino; Sachiko Inubushi; Y U Sun; Hyein Lim; Takeshi Aoki; Masahiko Murakami; Yoshihisa Takahashi; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

Authors:  Amandeep Singh; Phuc Le; Rocio Lopez; Naim Alkhouri
Journal:  Hepatol Int       Date:  2018-01-09       Impact factor: 6.047

4.  Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.

Authors:  Jing-Houng Wang; Hsin-You Ou; Yi-Hao Yen; Chien-Hung Chen; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

5.  Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.

Authors:  Noriyuki Koyama; Tomoko Yamazaki; Yuka Kanetsuki; Jiro Hirota; Tomohide Asai; Yasuhide Mitsumoto; Masayuki Mizuno; Toshihide Shima; Yoshihiro Kanbara; Satoko Arai; Toru Miyazaki; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2017-10-30       Impact factor: 7.527

6.  Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Jie Xing; Xue Guan; Qian Zhang; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Obes Facts       Date:  2021-03-29       Impact factor: 3.942

7.  Non-alcoholic fatty liver disease.

Authors:  Wenhao Li; William Alazawi
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

8.  Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Erin Cleveland; Andrew Bandy; Lisa B VanWagner
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-04-20

9.  Associations between dietary factors and markers of NAFLD in a general Dutch adult population.

Authors:  A Rietman; D Sluik; E J M Feskens; F J Kok; M Mensink
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

10.  Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.

Authors:  María José Morlán-Coarasa; María Teresa Arias-Loste; Víctor Ortiz-García de la Foz; Obdulia Martínez-García; Carmen Alonso-Martín; Javier Crespo; Manuel Romero-Gómez; Emilio Fábrega; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2016-09-12       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.